![AstraZeneca](/index.php/sites/default/files/styles/large/public/2021-01/AstraZeneca.jpg?itok=f3tSbsK8)
NEW DELHI (Reuters) - India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts were meeting for the second time this week, declined to comment.